Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Formulary and logistical considerations with the introduction of cell-based gene therapies

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Presentation
  • By: KIRSA, Suzanne (Monash Health, Australia)
  • Abstract:

    Gene Therapies are being commercialised across the world. These treatments are not conventional therapeutic products. Regulatory approvals differ across countries. Hospitals may choose approval and governance processes that by-pass the Pharmacy or Therapeutics committees unless Pharmacists actively pursue involvement. Toxicity profiles will

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses